Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA REFORM REVISIONS ON EVE OF SENATE DEBATE LEAVE MAIN PHARMACEUTICAL ISSUES UNRESOLVED; JULY 22 FLOOR TIME PLANNED BY SEN. LOTT IF TIME AGREEMENT REACHED

Executive Summary

A revised version of the Senate FDA reform bill (S 830) addresses numerous medical device-related issues but leaves most of the outstanding pharmaceutical-related provisions unresolved on the eve of floor debate.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030534

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel